Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway
- PMID: 27364889
- DOI: 10.1016/j.mce.2016.06.019
Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway
Abstract
Diabetic nephropathy (DN) is the leading cause of end-stage renal failure and is characterized by excessive deposition of extracellular matrix (ECM) proteins such as fibronectin (FN), in the glomerular mesangium and tubulointerstitium. Betulinic acid (BA), a pentacyclic triterpene derived from the bark of the white birch tree, has been demonstrated to have many pharmacological activities. However, the effect of BA on DN has not been fully elucidated. To explore the possible anti-inflammatory effects of BA and their underlying mechanisms, we used streptozotocin-induced diabetic rat kidneys and high glucose-treated glomerular mesangial cells. Our study showed BA could inhibit the degradation of IκBα and the activity of NF-κB in diabetic rat kidneys and high glucose-induced mesangial cells, resulting in reduction of FN expression. In addition, BA suppressed the DNA binding activity and transcriptional activity of NF-κB in high glucose-induced glomerular mesangial cells (GMCs). Furthermore, BA enhanced the interaction between IκBα and β-arrestin2 in mesangial cells. Taken together, our data suggest BA inhibits NF-κB activation through stabilizing NF-κB inhibitory protein IκBα, thereby preventing diabetic renal fibrosis.
Keywords: Betulinic acid; Diabetic nephropathy; Fibronectin; NF-κB.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells.Mol Cell Endocrinol. 2012 Oct 15;362(1-2):183-93. doi: 10.1016/j.mce.2012.06.008. Epub 2012 Jun 22. Mol Cell Endocrinol. 2012. PMID: 22732364
-
Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.Mol Cell Endocrinol. 2013 Dec 5;381(1-2):56-65. doi: 10.1016/j.mce.2013.07.019. Epub 2013 Jul 26. Mol Cell Endocrinol. 2013. PMID: 23896433
-
Betulinic acid inhibits cell proliferation and fibronectin accumulation in rat glomerular mesangial cells cultured under high glucose condition.Biomed Pharmacother. 2016 May;80:338-342. doi: 10.1016/j.biopha.2016.02.040. Epub 2016 Apr 6. Biomed Pharmacother. 2016. PMID: 27133074
-
Multiple molecular targets in breast cancer therapy by betulinic acid.Biomed Pharmacother. 2016 Dec;84:1321-1330. doi: 10.1016/j.biopha.2016.10.018. Epub 2016 Oct 29. Biomed Pharmacother. 2016. PMID: 27810789 Review.
-
Betulinic acid in the treatment of breast cancer: Application and mechanism progress.Fitoterapia. 2023 Sep;169:105617. doi: 10.1016/j.fitote.2023.105617. Epub 2023 Jul 20. Fitoterapia. 2023. PMID: 37479118 Review.
Cited by
-
Inhibition of miRNA‑135a‑5p ameliorates TGF‑β1‑induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy.Int J Mol Med. 2020 Sep;46(3):1063-1073. doi: 10.3892/ijmm.2020.4647. Epub 2020 Jun 17. Int J Mol Med. 2020. PMID: 32705273 Free PMC article.
-
Betulinic acid reduces the complications of autoimmune diabetes on the body and kidney through effecting on inflammatory cytokines in C57BL/6 mice.Vet Res Forum. 2021 Spring;12(2):203-210. doi: 10.30466/vrf.2019.101178.2409. Epub 2021 Jun 15. Vet Res Forum. 2021. PMID: 34345387 Free PMC article.
-
A Review on Preparation of Betulinic Acid and Its Biological Activities.Molecules. 2021 Sep 14;26(18):5583. doi: 10.3390/molecules26185583. Molecules. 2021. PMID: 34577056 Free PMC article. Review.
-
Exploring the Potential Mechanism of Tang-Shen-Ning Decoction against Diabetic Nephropathy Based on the Combination of Network Pharmacology and Experimental Validation.Evid Based Complement Alternat Med. 2021 Sep 9;2021:1025053. doi: 10.1155/2021/1025053. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34539795 Free PMC article.
-
Sphingosine kinase 1 mediates diabetic renal fibrosis via NF-κB signaling pathway: involvement of CK2α.Oncotarget. 2017 Oct 4;8(51):88988-89004. doi: 10.18632/oncotarget.21640. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179493 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous